Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen Seeking ESA Dosing Algorithm As Scripts Continue To Fall In Oncology

Executive Summary

Amgen is taking steps to construct dosing algorithms for its erythropoiesis-stimulating agents that may help mitigate problems stemming from heterogeneous patient response to the anemia therapies
Advertisement

Related Content

Amgen, J&J Propose New Target Range For Aranesp, Procrit
Amgen, J&J Propose New Target Range For Aranesp, Procrit
ESA Labeling Should Explain Hemoglobin Target, Advisory Committee Says
ESA Labeling Should Explain Hemoglobin Target, Advisory Committee Says
Aranesp Bad Luck Catches Up To Amgen, Forces Pharma-Style Reorganization
Advertisement
UsernamePublicRestriction

Register

PS048832

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel